Hepatitis B Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: H81BDA3C3C65EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hepatitis B Therapeutics in Global, including the following market information:

Global Hepatitis B Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hepatitis B Therapeutics market was valued at 2563.9 million in 2021 and is projected to reach US$ 3125.7 million by 2028, at a CAGR of 2.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hepatitis B Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatitis B Therapeutics include GlaxoSmithKline, Bristol-Myers Squibb, Novira Therapeutics, Johnson & Johnson, Abivax, F. Hoffmann- La Roche, Novartis and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis B Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis B Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis B Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Hepatitis B Vaccine
• Anti-viral Drugs

Global Hepatitis B Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis B Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Hepatitis B Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hepatitis B Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis B Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hepatitis B Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Bristol-Myers Squibb
• Novira Therapeutics
• Johnson & Johnson
• Abivax
• F. Hoffmann- La Roche
• Novartis
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatitis B Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatitis B Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATITIS B THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Hepatitis B Therapeutics Market Size: 2021 VS 2028
2.2 Global Hepatitis B Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hepatitis B Therapeutics Players in Global Market
3.2 Top Global Hepatitis B Therapeutics Companies Ranked by Revenue
3.3 Global Hepatitis B Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis B Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Hepatitis B Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hepatitis B Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Hepatitis B Vaccine
  4.1.3 Anti-viral Drugs
4.2 By Type - Global Hepatitis B Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Hepatitis B Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Hepatitis B Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatitis B Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Hepatitis B Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Hepatitis B Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Hepatitis B Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hepatitis B Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis B Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Hepatitis B Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Hepatitis B Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hepatitis B Therapeutics Revenue, 2017-2028
  6.3.2 US Hepatitis B Therapeutics Market Size, 2017-2028
  6.3.3 Canada Hepatitis B Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Hepatitis B Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hepatitis B Therapeutics Revenue, 2017-2028
  6.4.2 Germany Hepatitis B Therapeutics Market Size, 2017-2028
  6.4.3 France Hepatitis B Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Hepatitis B Therapeutics Market Size, 2017-2028
  6.4.5 Italy Hepatitis B Therapeutics Market Size, 2017-2028
  6.4.6 Russia Hepatitis B Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Hepatitis B Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Hepatitis B Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hepatitis B Therapeutics Revenue, 2017-2028
  6.5.2 China Hepatitis B Therapeutics Market Size, 2017-2028
  6.5.3 Japan Hepatitis B Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Hepatitis B Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Hepatitis B Therapeutics Market Size, 2017-2028
  6.5.6 India Hepatitis B Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hepatitis B Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Hepatitis B Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Hepatitis B Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Hepatitis B Therapeutics Market Size, 2017-2028
  6.7.3 Israel Hepatitis B Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Hepatitis B Therapeutics Market Size, 2017-2028
  6.7.5 UAE Hepatitis B Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Hepatitis B Therapeutics Major Product Offerings
  7.1.4 GlaxoSmithKline Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Major Product Offerings
  7.2.4 Bristol-Myers Squibb Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Novira Therapeutics
  7.3.1 Novira Therapeutics Corporate Summary
  7.3.2 Novira Therapeutics Business Overview
  7.3.3 Novira Therapeutics Hepatitis B Therapeutics Major Product Offerings
  7.3.4 Novira Therapeutics Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Novira Therapeutics Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Hepatitis B Therapeutics Major Product Offerings
  7.4.4 Johnson & Johnson Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Abivax
  7.5.1 Abivax Corporate Summary
  7.5.2 Abivax Business Overview
  7.5.3 Abivax Hepatitis B Therapeutics Major Product Offerings
  7.5.4 Abivax Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Abivax Key News
7.6 F. Hoffmann- La Roche
  7.6.1 F. Hoffmann- La Roche Corporate Summary
  7.6.2 F. Hoffmann- La Roche Business Overview
  7.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Major Product Offerings
  7.6.4 F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 F. Hoffmann- La Roche Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Hepatitis B Therapeutics Major Product Offerings
  7.7.4 Novartis Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck Hepatitis B Therapeutics Major Product Offerings
  7.8.4 Merck Hepatitis B Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hepatitis B Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Therapeutics Market Drivers in Global Market
Table 3. Hepatitis B Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Therapeutics in Global Market
Table 5. Top Hepatitis B Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis B Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis B Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis B Therapeutics Product Type
Table 9. List of Global Tier 1 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis B Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis B Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Hepatitis B Therapeutics Product Offerings
Table 32. GlaxoSmithKline Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Hepatitis B Therapeutics Product Offerings
Table 35. Bristol-Myers Squibb Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novira Therapeutics Corporate Summary
Table 37. Novira Therapeutics Hepatitis B Therapeutics Product Offerings
Table 38. Novira Therapeutics Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Hepatitis B Therapeutics Product Offerings
Table 41. Johnson & Johnson Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Abivax Corporate Summary
Table 43. Abivax Hepatitis B Therapeutics Product Offerings
Table 44. Abivax Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. F. Hoffmann- La Roche Corporate Summary
Table 46. F. Hoffmann- La Roche Hepatitis B Therapeutics Product Offerings
Table 47. F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Hepatitis B Therapeutics Product Offerings
Table 50. Novartis Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Hepatitis B Therapeutics Product Offerings
Table 53. Merck Hepatitis B Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hepatitis B Therapeutics Segment by Type in 2021
Figure 2. Hepatitis B Therapeutics Segment by Application in 2021
Figure 3. Global Hepatitis B Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis B Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2021
Figure 8. By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis B Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novira Therapeutics Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abivax Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)